Erin Ventures Completes Private Placement

July 27, 2012

Erin Ventures Inc. (TSX-Venture: EV) is pleased to announce that it has completed its private placement of units at a price of $0.06 per unit. A total of 19,214,996 units have been issued for total proceeds in the amount of $1,152,899.76. Each unit consists of one common share and one warrant. The warrants have a two year term with an exercise price of $0.12 in the first year and $0.25 in the second year. Finder’s fees totaling $51,160 are being paid with respect to this placement. The proceeds of this placement will be used by Erin Ventures Inc. to fund exploration expenses, in addition to general and administrative expenses and working capital. The securities issued in this placement are subject to a hold period expiring November 27, 2012.

On behalf of the Board of Directors,
Blake Fallis, General Manager

For further information, please contact:
Erin Ventures Inc. Canada
Blake Fallis, General Manager TSX Venture: EV
Phone: 1-250- 384-1999 or 1-888-289-3746 USA
www.erinventures.com

Erin's Public Quotations:
Canada
TSX Venture: EV
USA
SEC 12G3-2(B) #82-4432
OTCBB: ERVFF
Europe
Berlin Stock Exchange: EKV

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements
This release contains forward looking statements. The words "believe," "expect," "feel," "plan," "anticipate," "project," "could," "should" and other similar expressions generally identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties including, without limitation, variations in estimated costs, the failure to discover or recover economic grades of minerals, and the inability to raise the funds necessary, changes in external market factors including commodity prices, and other risks and uncertainties. Actual results could differ materially from the results referred to in the forward-looking statements.